BiotechTube
Home/Rani Therapeutics/Mir Imran
MI

Mir Imran

Founder and Chairman

Rani Therapeutics

Therapeutic Areas

OsteoporosisInflammatory DiseasesImmunology

Rani Therapeutics Pipeline

DrugIndicationPhase
RT-102Osteoporosis (Parathyroid Hormone Analog)Phase 1
RT-111Inflammatory Diseases (Ustekinumab Biosimilar)Phase 1

Leadership Team at Rani Therapeutics

TI
Talat Imran
Chief Executive Officer
View full Rani Therapeutics profile